Dexamethasone for alcohol withdrawal.

Ann Intern Med

Published: April 1991

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-114-8-705DOI Listing

Publication Analysis

Top Keywords

dexamethasone alcohol
4
alcohol withdrawal
4
dexamethasone
1
withdrawal
1

Similar Publications

Purpose: This study aims to provide new insights into the potential of oyster mushroom () ethanolic extract in preventing obesity through the inhibition of expression and modulation of methylation level on promoter during 3T3-L1 adipocyte differentiation.

Methods: This in vitro quantitative experimental study was conducted by treating the 3T3-L1 cell line differentiated using 0.5 mM methyl-isobutyl-xanthine, 1 μM dexamethasone, and 10 μg/mL insulin-containing medium with oyster mushroom ethanolic extract.

View Article and Find Full Text PDF

Osteoporosis, a common metabolic bone disorder, leads to increased fracture risk and significant morbidity, particularly in postmenopausal women and the elderly. Traditional treatments often fail to fully restore bone health and may cause side effects, prompting the exploration of regenerative therapies. Adipose-derived stem cells (ADSCs) offer potential for osteoporosis treatment, but their natural inclination toward adipogenic rather than osteogenic differentiation poses a challenge.

View Article and Find Full Text PDF

Aimed to enhance the anti-inflammatory activity of caffeic acid phenethyl ester (CAPE), the oxadiazole derivatives were synthesized by substituting its ester group. The structure-activity relationships revealed that the electron-withdrawing group in the phenethyl moiety enhanced anti-inflammatory activity. The order of activity potency was F ≥ CF > Cl > NO > CN.

View Article and Find Full Text PDF

Muscle atrophy, an age-related condition, presents a growing healthcare concern within the context of global population aging. While studies have investigated for its potential antifatigue properties, reports on its active components remain limited. This study evaluated the efficacy of mycelium extract on muscle health, utilizing a 1:1 water-ethanol preparation administered to C57BL/6 mice exhibiting acute hind leg atrophy.

View Article and Find Full Text PDF

Background: Previously, Japanese Environmental Mutagen and Genome Society/Mammalian Mutagenicity Study Group/Toxicogenomics Study Group (JEMS/MMS toxicogenomic study group) proposed 12 genotoxic marker genes (Aen, Bax, Btg2, Ccnf, Ccng1, Cdkn1a, Gdf15, Lrp1, Mbd1, Phlda3, Plk2, and Tubb4b) to discriminate genotoxic hepatocarcinogens (GTHCs) from non-genotoxic hepatocarcinogens (NGTHCs) and non-genotoxic non-hepatocarcinogens (NGTNHCs) in mouse and rat liver using qPCR and RNA-Seq and confirmed in public rat toxicogenomics data, Open TG-GATEs, by principal component analysis (PCA). On the other hand, the U.S.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!